IRLAB A — IRLAB Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for IRLAB Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	277	402	253	111	66.9
Net Total Accounts Receivable
Net Total Receivables	4.71	10.7	9.83	9.17	12.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	284	421	269	124	79.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.32	8.35	8.01	6.67	9.79
Net Intangible Assets
Other Long Term Assets
Total Assets	370	472	324	177	136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.9	69.4	32.3	36.7	100
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	22.2	73	32.7	61.4	104
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	348	399	291	116	32.6
Total Liabilities & Shareholders' Equity	370	472	324	177	136
Total Common Shares Outstanding